Medicines Formulary

Reports

Drug name	NICE TAs	Comments
Iron-hydroxide sucrose complex injection (Venofer)
Isatuximab	TA658 - Isatuximab with pomalidomide and dexamethasone for treating relapsed and refractory multiple myeloma
Isoflurane
Isoplex infusion		For use in liver theatres only.
Isoprenaline injection		Hospital use only
Isosorbide dinitrate		Hospital use only
Isotretinoin capsules		Contraindicated in pregnancy
IV fluids		Hospital only
Ixekizumab (Taltz®)	TA422 - Ixekizumab for treating moderate to severe plaque psoriasis TA718 - Ixekizumab for treating axial spondyloarthritis
Juvederm Ultra XC		Cleft service only

First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
Next page
Last page

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.